Private equity has found a new favorite aisle. Vitamins and dietary supplements, once dismissed as a fragmented cottage industry, are now drawing serious consolidation capital. Through year-to-date 2026, M&A activity in the category has strengthened materially, with PE firms cited as a primary driver alongside durable consumer demand that has proven resilient across economic cycles.
If you're operating a supplement brand, a fitness-adjacent nutrition line, or even a gym with a retail component, this shift has direct consequences for how you compete, price, and position your business going forward.
The Size of the Prize
The global dietary supplements market is on track to approach $300 billion in value by 2031. That figure alone explains why institutional capital is paying attention. Categories growing at that scale, with relatively low manufacturing complexity and strong repeat purchase behavior, are exactly what PE roll-up strategies are built for.
Consumer demand is holding. Health and wellness spending has shown consistent resilience even as discretionary categories softened in 2023 and 2024. Supplements, particularly those tied to protein, longevity, gut health, and metabolic performance, have continued to grow both in unit volume and average transaction value. That combination of durable demand and category fragmentation is precisely the entry signal PE firms look for before deploying capital at scale.
For independent brands, the implication is straightforward: the window to establish differentiated positioning before the category consolidates around a handful of well-capitalized platforms is narrowing.
The Fitness Roll-Up Playbook, Applied to Supplements
This dynamic isn't new to the fitness industry. PE-backed roll-up strategies have already reshaped the gym sector. Crunch Fitness, Planet Fitness franchisee groups, and Anytime Fitness networks have all benefited from scale advantages that individual operators simply can't match: lower supplier costs, national marketing budgets, and preferential retail and real estate terms.
The same logic is now being applied to the supplement shelf. As larger platforms absorb independent brands, they gain pricing leverage with distributors, preferred placement with major retail chains, and the marketing spend to dominate search and social. Providence Buys Fitness Park: European Gym Consolidation Accelerates offers a parallel worth studying. What played out in European gym networks is now playing out in supplement aisles globally: scale becomes the moat, and independent operators compete on increasingly unfavorable terms.
For supplement founders, this means that shelf space, which was already competitive, is becoming structurally harder to access without either PE backing or a highly differentiated product story. Distribution agreements that once went to the best product are increasingly going to the best-capitalized brand.
Fitness Conglomerates Are Freeing Capital for Adjacent Moves
One of the more telling signals in 2026 came from Xponential Fitness. The company divested Rumble Boxing and CycleBar to Extraordinary Brands, a move that reflects a broader strategic pruning trend across fitness conglomerates. When a holding company sheds non-core brands, it's not just simplifying. It's redeploying. And adjacent categories, including nutrition, supplements, and recovery products, are logical landing spots for that freed capital.
You can read more about the strategic logic behind these moves in Xponential's Poison Pill: What It Signals for Boutique Fitness M&A. The pattern is consistent: fitness platforms that consolidate around core competencies tend to look outward toward adjacent consumer health categories once their balance sheets are optimized.
This creates a secondary wave of acquisition interest in supplements that doesn't come only from pure-play PE firms. It also comes from fitness and wellness conglomerates looking to expand their consumer touchpoints beyond the gym floor or the studio membership.
What Category Multiples Actually Mean for Brand Operators
PE activity compresses multiples over time. When a category first attracts institutional interest, early platform acquisitions happen at premium valuations. Sellers get strong terms. But as the roll-up matures and a few large players control significant market share, buyers gain leverage. Smaller brands that delay positioning themselves as acquisition targets or strategic partners often find that the multiple they could have commanded in 2024 or 2025 is no longer available in 2027 or 2028.
This is not speculation. It's the documented pattern from adjacent categories: sports nutrition in the 2010s, the protein bar segment, and functional beverages all followed this arc. The brands that captured premium exits did so early and with clear differentiation. Those that waited either sold at compressed valuations or were priced out of retail entirely by better-funded competitors.
The strategic calculus for supplement brands operating right now breaks down into three defensible positions.
Three Positions Worth Building Now
- Proprietary consumer data. First-party data is the asset PE acquirers value most highly after the brand itself. If you're selling primarily through third-party retailers with no direct consumer relationship, you're building revenue without building an asset. DTC channels, loyalty programs, and app-based engagement all create data infrastructure that elevates your acquisition profile and your negotiating position.
- Subscription revenue. Recurring revenue commands higher multiples across every consumer category. Subscription models in supplements also generate behavioral data that informs product development and customer lifetime value modeling. The wearable sector has demonstrated this clearly. WHOOP and Ultrahuman Show Where Wearable Money Is Going illustrates how subscription infrastructure is now a primary driver of institutional valuation, not just a revenue line.
- Clinical differentiation. Third-party studies, peer-reviewed efficacy data, and transparent ingredient sourcing are increasingly the credibility signals that allow independent brands to hold shelf space and price premium against PE-backed competitors. Efficacy claims backed by research are harder to commoditize. Pea Protein Supports Muscle Growth, Review Confirms is the kind of validated narrative that moves product and builds category authority simultaneously. If your formulations can generate that kind of evidence, you have a defensible moat that capital alone can't replicate overnight.
The Distribution Squeeze Is Already Happening
Major retailers are under their own margin pressure. As PE-backed supplement platforms offer better slotting terms, more consistent supply chains, and larger co-op marketing budgets, independent brands are losing ground at the shelf level. This is not a prediction. Buyers at major chains and specialty health retailers are already prioritizing vendors who can demonstrate operational scale and financial stability.
Online channels remain more accessible, but they're not immune to consolidation either. Amazon shelf position increasingly reflects advertising spend, and PE-backed brands can outspend independents on sponsored placements for sustained periods. The economics of customer acquisition are shifting in favor of capitalized platforms.
This doesn't mean independent brands can't compete. It means competing on the same terms as PE-backed players is no longer viable. The strategic path forward requires either differentiation that capital can't easily replicate, or positioning your brand as an attractive acquisition before you're competing from a position of weakness.
The Window Is Defined, Not Open-Ended
Supplement M&A cycles follow the same compressed timeline as other high-growth consumer categories. The PE interest that's intensifying through 2026 will produce dominant platforms by 2028 or 2029. By that point, the category's power structure will largely be set. Independent brands competing for retail terms, marketing spend, and consumer trust will be doing so against organizations with structural advantages they cannot overcome organically.
The brands navigating this well are the ones treating 2026 as a build year. Build your direct consumer relationship. Build subscription infrastructure. Build clinical credibility. If you're also working on the athlete side of your business, the physical performance connection matters here too. Supplement brands that can tie their products to structured training outcomes, the kind of programs outlined in resources like Winter Strength Block: Program Your Next 12 Weeks, have a consumer engagement narrative that PE-assembled portfolios often struggle to replicate with authenticity.
The capital is coming. The consolidation is underway. The question isn't whether the supplement category restructures around institutional ownership. It's whether your brand is positioned to benefit from that dynamic or displaced by it.